Viewing Study NCT05111366


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-01-04 @ 3:41 AM
Study NCT ID: NCT05111366
Status: UNKNOWN
Last Update Posted: 2022-05-04
First Post: 2021-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection
Sponsor: Xianhai Mao
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module